Virtus Investment Advisers »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $45k 38k 1.19
2024-06-30 $42k 38k 1.11
2024-03-31 $37k 38k 0.97

More positions owned by Virtus Investment Advisers

Icici Bank Adr (IBN)
Virtus Etf Tr Ii Duff & Phelps Cl (VCLN)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Microsoft Corporation (MSFT)
Taylor Morrison Hom (TMHC)
CommVault Systems (CVLT)
Veracyte (VCYT)
Apple (AAPL)
Barrett Business Services (BBSI)
Kirby Corporation (KEX)
Knife River Corp Common Stock (KNF)
NVIDIA Corporation (NVDA)
Adma Biologics (ADMA)
Nmi Hldgs Inc cl a (NMIH)
Zeta Global Holdings Corp Cl A (ZETA)

View all positions for Virtus Investment Advisers

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Camden Asset Management
Millennium Management
Citadel Advisors
MacKay Shields
Lazard Asset Management
Polar Securities
Calamos Advisors
Wolverine Asset Management
Ing Investment Management
Leucadia National Corporation
Wells Fargo & Company
Bank Of Montreal
CNH Partners
DeepCurrents Investment Group

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1